Bill Commons

VA SB 271

vetoed

Prescription Drug Affordability Board; established.

Virginia · 2026 Regular Session · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did VA SB 271 pass?

No. VA SB 271 passed the legislature but was vetoed. Latest recorded action (2026-04-13): Governor's recommendation received by Senate

What is VA SB 271 about?

Prescription Drug Affordability Advisory Panel established; maximum fair price; annual reports; civil penalties. Directs the Secretary of Health and Human Resources to establish the Prescription Drug Affordability Advisory Panel to conduct data analyses, develop policy recommendations, and identify implementation barriers related to strategies to improve prescription drug affordability, enhance price transparency, and strengthen data collection practices for prescription drugs across public and private payers. The bill requires the Panel to (i) report annually on prescription drug pricing trends and any policy recommendations on legislation to improve prescription drug affordability and (ii) provide quarterly updates on prescription drug pricing trends. The bill requires each pharmacy benefits manager to provide to the Panel, upon request, certain information relating to the dispensation of a referenced drug, as defined in the bill.The bill prohibits prescription drug manufacturers or wholesale distributors permitted or licensed in the Commonwealth from accepting payment at an amount higher than the maximum fair price established by the U.S. Secretary of Health and Human Services pursuant to federal law for the sale of a referenced drug intended for use by individuals in the Commonwealth. Under the bill, an entity that violates such prohibition is subject to a civil penalty of $10,000 per violation. The bill also prohibits a manufacturer subject to its provisions from removing a referenced drug from sale distribution in the Commonwealth for the purpose of avoiding the impact of the bill's rate limitations without providing certain prior notice. Under the bill, a manufacturer that violates such prohibition on removing a referenced drug without the required notice is subject to a civil penalty equal to the greater of $100,000 or the total amount of annual savings for the referenced drug, as determined by the Board of Pharmacy. This bill is identical to HB 483.

Who sponsors VA SB 271?

R. Creigh Deeds is the primary sponsor of VA SB 271, joined by 1 cosponsor.

Description

Prescription Drug Affordability Advisory Panel established; maximum fair price; annual reports; civil penalties. Directs the Secretary of Health and Human Resources to establish the Prescription Drug Affordability Advisory Panel to conduct data analyses, develop policy recommendations, and identify implementation barriers related to strategies to improve prescription drug affordability, enhance price transparency, and strengthen data collection practices for prescription drugs across public and private payers. The bill requires the Panel to (i) report annually on prescription drug pricing trends and any policy recommendations on legislation to improve prescription drug affordability and (ii) provide quarterly updates on prescription drug pricing trends. The bill requires each pharmacy benefits manager to provide to the Panel, upon request, certain information relating to the dispensation of a referenced drug, as defined in the bill.The bill prohibits prescription drug manufacturers or wholesale distributors permitted or licensed in the Commonwealth from accepting payment at an amount higher than the maximum fair price established by the U.S. Secretary of Health and Human Services pursuant to federal law for the sale of a referenced drug intended for use by individuals in the Commonwealth. Under the bill, an entity that violates such prohibition is subject to a civil penalty of $10,000 per violation. The bill also prohibits a manufacturer subject to its provisions from removing a referenced drug from sale distribution in the Commonwealth for the purpose of avoiding the impact of the bill's rate limitations without providing certain prior notice. Under the bill, a manufacturer that violates such prohibition on removing a referenced drug without the required notice is subject to a civil penalty equal to the greater of $100,000 or the total amount of annual savings for the referenced drug, as determined by the Board of Pharmacy. This bill is identical to HB 483.

Introduced
2026-01-12
Latest action
2026-04-13 — Governor's recommendation received by Senate
Bill type
bill
Last updated
—

Sponsors

  • R. Creigh Deedsprimary
  • Jennifer D. Carroll Foycosponsor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-04-13

    Governor's recommendation received by Senate

    executive-veto-line-item

  2. 2026-03-31

    Governor's Action Deadline 11:59 p.m., April 13, 2026

    executive-receipt

  3. 2026-03-31

    Enrolled Bill communicated to Governor on March 31, 2026

    enrolled,executive-receipt

  4. 2026-03-31

    Signed by Speaker

    passage

  5. 2026-03-31

    Fiscal Impact Statement from Department of Planning and Budget (SB271)

  6. 2026-03-30

    Signed by President

    passage

  7. 2026-03-30

    Bill text as passed Senate and House (SB271ER)

    passage

  8. 2026-03-30

    Enrolled

    enrolled

  9. 2026-03-23

    Fiscal Impact Statement from Department of Planning and Budget (SB271)

  10. 2026-03-11

    House substitute agreed to by Senate

    substitution

  11. 2026-03-10

    Passed House with substitute (95-Y 4-N 0-A)

    passage

  12. 2026-03-10

    Engrossed by House - floor substitute

  13. 2026-03-10

    Delegate Delaney Floor substitute agreed to

    substitution

  14. 2026-03-10

    Delegate Delaney Floor amendments withdrawn

    withdrawal

  15. 2026-03-10

    Delegate Delaney Substitute withdrawn by House

    withdrawal

  16. 2026-03-10

    Read third time

    reading-3

  17. 2026-03-10

    Floor offered Delegate Delaney Substitute

  18. 2026-03-10

    Floor substitute printed 26109555D-H2 (Delaney)

  19. 2026-03-09

    Passed by for the day

  20. 2026-03-09

    Passed by temporarily

  21. 2026-03-09

    Read third time

    reading-3

  22. 2026-03-09

    Floor offered Delegate Delaney Amendments

  23. 2026-03-09

    Floor offered Delegate Delaney Substitute

  24. 2026-03-09

    Floor substitute printed 26109393D-H1 (Delaney)

  25. 2026-03-06

    Read second time

    reading-2

  26. 2026-03-04

    Reported from Appropriations (17-Y 5-N)

    committee-passage

  27. 2026-02-12

    Referred to Committee on Appropriations

    referral-committee

  28. 2026-02-12

    Read first time

    reading-1

  29. 2026-02-12

    Placed on Calendar

  30. 2026-02-11

    Assigned HAPP sub: Health & Human Resources

    referral-committee

  31. 2026-02-10

    Fiscal Impact Statement from Department of Planning and Budget (SB271)

  32. 2026-02-06

    Read third time and passed Senate (31-Y 8-N 0-A)

    passage,reading-3

  33. 2026-02-05

    Engrossed by Senate as amended (Voice Vote)

  34. 2026-02-05

    Commerce and Labor Amendments agreed to

    amendment-passage

  35. 2026-02-05

    Read second time

    reading-2

  36. 2026-02-04

    Passed by for the day Block Vote (Voice Vote)

  37. 2026-02-04

    Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)

  38. 2026-02-04

    Rules suspended

  39. 2026-02-03

    Reported from Finance and Appropriations (9-Y 5-N 1-A)

    committee-passage

  40. 2026-01-27

    Fiscal Impact Statement from Department of Planning and Budget (SB271)

  41. 2026-01-26

    Reported from Commerce and Labor with amendments and rereferred to Finance and Appropriations (10-Y 4-N 1-A)

    committee-passage

  42. 2026-01-26

    Senate committee offered

  43. 2026-01-22

    Rereferred from Education and Health to Commerce and Labor (14-Y 0-N)

    referral-committee

  44. 2026-01-12

    Referred to Committee on Education and Health

    referral-committee

  45. 2026-01-12

    Prefiled and ordered printed; Offered 01-14-2026 26105318D

    filing,introduction

Versions

Documents

Votes

  • Rereferred from Education and Health

    2026-01-22 · pass · 14-0

    Member-level votes (15)
    • Barbara A. Favola: yes
    • L. Louise Lucas: yes
    • Mamie E. Locke: yes
    • David R. Suetterlein: yes
    • Mark J. Peake: yes
    • Todd E. Pillion: yes
    • Jennifer B. Boysko: not voting
    • Lamont Bagby: yes
    • Christopher T. Head: yes
    • Lashrecse D. Aird: yes
    • Schuyler T. VanValkenburg: yes
    • Tara A. Durant: yes
    • Stella G. Pekarsky: yes
    • Christie New Craig: yes
    • Russet Perry: yes
  • Reported from Commerce and Labor with amendments

    2026-01-26 · pass · 10-4

    Member-level votes (15)
    • R. Creigh Deeds: yes
    • Mark D. Obenshain: no
    • L. Louise Lucas: yes
    • David W. Marsden: abstain
    • Adam P. Ebbin: yes
    • Scott A. Surovell: yes
    • William M. Stanley, Jr.: yes
    • Ryan T. McDougle: no
    • Mamie E. Locke: yes
    • Bryce E. Reeves: no
    • Bill DeSteph: no
    • Jeremy S. McPike: yes
    • Mark J. Peake: yes
    • Aaron R. Rouse: yes
    • Lamont Bagby: yes
  • Reported from Finance and Appropriations

    2026-02-03 · pass · 9-5

    Member-level votes (15)
    • L. Louise Lucas: yes
    • R. Creigh Deeds: yes
    • Mamie E. Locke: yes
    • David W. Marsden: abstain
    • Adam P. Ebbin: yes
    • Ryan T. McDougle: no
    • Mark D. Obenshain: no
    • Richard H. Stuart: no
    • Bryce E. Reeves: no
    • Barbara A. Favola: yes
    • Scott A. Surovell: yes
    • Jeremy S. McPike: yes
    • Jennifer B. Boysko: yes
    • Todd E. Pillion: no
    • Aaron R. Rouse: yes
  • Constitutional reading dispensed R

    2026-02-04 · pass · 40-0

    Member-level votes (40)
    • Lashrecse D. Aird: yes
    • Lamont Bagby: yes
    • Jennifer B. Boysko: yes
    • Jennifer D. Carroll Foy: yes
    • Luther Cifers, III: yes
    • Christie New Craig: yes
    • R. Creigh Deeds: yes
    • Bill DeSteph: yes
    • J.D. "Danny" Diggs: yes
    • Tara A. Durant: yes
    • Adam P. Ebbin: yes
    • Barbara A. Favola: yes
    • Timmy French: yes
    • T. Travis Hackworth: yes
    • Christopher T. Head: yes
    • Michael J. Jones: yes
    • Emily M. Jordan: yes
    • Mamie E. Locke: yes
    • L. Louise Lucas: yes
    • David W. Marsden: yes
    • Ryan T. McDougle: yes
    • Jeremy S. McPike: yes
    • Tammy Brankley Mulchi: yes
    • Mark D. Obenshain: yes
    • Mark J. Peake: yes
    • Stella G. Pekarsky: yes
    • Russet Perry: yes
    • Todd E. Pillion: yes
    • Bryce E. Reeves: yes
    • Danica A. Roem: yes
    • Aaron R. Rouse: yes
    • Saddam Azlan Salim: yes
    • Kannan Srinivasan: yes
    • William M. Stanley, Jr.: yes
    • Richard H. Stuart: yes
    • Glen H. Sturtevant, Jr.: yes
    • David R. Suetterlein: yes
    • Scott A. Surovell: yes
    • Schuyler T. VanValkenburg: yes
    • Angelia Williams Graves: yes
  • Passage R

    2026-02-06 · pass · 31-8

    Member-level votes (40)
    • Lashrecse D. Aird: yes
    • Lamont Bagby: yes
    • Jennifer B. Boysko: yes
    • Jennifer D. Carroll Foy: yes
    • Luther Cifers, III: yes
    • Christie New Craig: no
    • R. Creigh Deeds: yes
    • Bill DeSteph: no
    • J.D. "Danny" Diggs: yes
    • Tara A. Durant: no
    • Adam P. Ebbin: yes
    • Barbara A. Favola: yes
    • Timmy French: yes
    • T. Travis Hackworth: no
    • Christopher T. Head: yes
    • Michael J. Jones: yes
    • Emily M. Jordan: yes
    • Mamie E. Locke: yes
    • L. Louise Lucas: yes
    • David W. Marsden: not voting
    • Ryan T. McDougle: no
    • Jeremy S. McPike: yes
    • Tammy Brankley Mulchi: no
    • Mark D. Obenshain: no
    • Mark J. Peake: yes
    • Stella G. Pekarsky: yes
    • Russet Perry: yes
    • Todd E. Pillion: yes
    • Bryce E. Reeves: yes
    • Danica A. Roem: yes
    • Aaron R. Rouse: yes
    • Saddam Azlan Salim: yes
    • Kannan Srinivasan: yes
    • William M. Stanley, Jr.: yes
    • Richard H. Stuart: no
    • Glen H. Sturtevant, Jr.: yes
    • David R. Suetterlein: yes
    • Scott A. Surovell: yes
    • Schuyler T. VanValkenburg: yes
    • Angelia Williams Graves: yes
  • Reported from Appropriations

    2026-03-04 · pass · 17-5

    Member-level votes (22)
    • Luke E. Torian: yes
    • Betsy B. Carr: yes
    • Delores L. McQuinn: yes
    • Paul E. Krizek: yes
    • C.E. Cliff Hayes, Jr.: yes
    • David A. Reid: yes
    • Rodney T. Willett: yes
    • Briana D. Sewell: yes
    • Alex Q. Askew: yes
    • Charniele L. Herring: yes
    • Marcia S. "Cia" Price: yes
    • Kathy K.L. Tran: yes
    • Shelly A. Simonds: yes
    • Joshua E. Thomas: yes
    • Amy J. Laufer: yes
    • Terry L. Austin: no
    • James W. Morefield: yes
    • Robert S. Bloxom, Jr.: no
    • M. Keith Hodges: no
    • Scott A. Wyatt: no
    • Bill Wiley: no
    • Ellen H. McLaughlin: yes
  • H VOTE:

    2026-03-10 · pass · 95-4

    Member-level votes (99)
    • Jessica L. Anderson: yes
    • Bonita G. Anthony: yes
    • Alex Q. Askew: yes
    • Terry L. Austin: yes
    • Jason S. Ballard: yes
    • Robert S. Bloxom, Jr.: yes
    • Gretchen M. Bulova: yes
    • Katrina Callsen: yes
    • Karen R. "Kacey" Carnegie: yes
    • Betsy B. Carr: yes
    • Stacey Annie Carroll: yes
    • Mike A. Cherry: yes
    • Nadarius E. Clark: yes
    • Laura Jane Cohen: yes
    • Joshua G. Cole: yes
    • Nicole Cole: yes
    • Kelly K. Convirs-Fowler: yes
    • Mitchell Cornett: yes
    • Rae Cousins: yes
    • Will Davis: yes
    • Karrie K. Delaney: yes
    • Lindsey Dougherty: yes
    • Mark C. Downey: yes
    • Michael B. Feggans: yes
    • Hyland F. "Buddy" Fowler, Jr.: yes
    • Lily V. Franklin: yes
    • Margaret A. Franklin: yes
    • Debra D. Gardner: yes
    • Thomas A. Garrett, Jr.: no
    • Jackie H. Glass: yes
    • Timothy P. Griffin: no
    • Elizabeth R. Guzman: yes
    • Karen Hamilton: no
    • C.E. Cliff Hayes, Jr.: yes
    • Dan I. Helmer: yes
    • Rozia A. Henson, Jr.: yes
    • Phil M. Hernandez: yes
    • Charniele L. Herring: yes
    • M. Keith Hodges: yes
    • Patrick A. Hope: yes
    • Hillary Pugh Kent: yes
    • Karen Keys-Gamarra: yes
    • Terry G. Kilgore: yes
    • Paul E. Krizek: yes
    • Amy J. Laufer: yes
    • James A. "Jay" Leftwich: yes
    • Destiny LeVere Bolling: yes
    • Alfonso H. Lopez: yes
    • Michelle Lopes Maldonado: yes
    • Marty Martinez: yes
    • John Chilton McAuliff: yes
    • Adele Y. McClure: yes
    • Garrett McGuire: yes
    • Ellen H. McLaughlin: yes
    • Joseph P. McNamara: yes
    • Kirk McPike: yes
    • Delores L. McQuinn: yes
    • Leslie Chambers Mehta: yes
    • James W. Morefield: yes
    • May Nivar: yes
    • Delores Oates: yes
    • Israel D. O'Quinn: yes
    • Justin Pence: yes
    • Eric Phillips: yes
    • Kimberly Pope Adams: yes
    • Marcia S. "Cia" Price: yes
    • Sam Rasoul: yes
    • Atoosa R. Reaser: yes
    • David A. Reid: yes
    • Chris S. Runion: yes
    • Charlie Schmidt: yes
    • Don Scott: yes
    • Phillip A. Scott: no
    • Holly M. Seibold: yes
    • Briana D. Sewell: yes
    • Irene Shin: yes
    • Marcus B. Simon: yes
    • Shelly A. Simonds: yes
    • JJ Singh: yes
    • Richard C. "Rip" Sullivan, Jr.: yes
    • Anne Ferrell Tata: yes
    • Joshua E. Thomas: yes
    • Virgil Thornton: yes
    • Luke E. Torian: yes
    • Kathy K.L. Tran: yes
    • H. Otto Wachsmann, Jr.: yes
    • Wendell S. Walker: yes
    • Jeion A. Ward: yes
    • R. Lee Ware: yes
    • Vivian E. Watts: yes
    • Michael J. Webert: yes
    • Madison Whittle: yes
    • Bill Wiley: yes
    • Rodney T. Willett: yes
    • Wren M. Williams: yes
    • Tony O. Wilt: yes
    • Thomas C. Wright, Jr.: yes
    • Scott A. Wyatt: yes
    • Eric R. Zehr: yes
  • Concur House Substitute R

    2026-03-11 · pass · 32-8

    Member-level votes (40)
    • Lashrecse D. Aird: yes
    • Lamont Bagby: yes
    • Elizabeth B. Bennett-Parker: yes
    • Jennifer B. Boysko: yes
    • Jennifer D. Carroll Foy: yes
    • Luther Cifers, III: no
    • Christie New Craig: no
    • R. Creigh Deeds: yes
    • Bill DeSteph: no
    • J.D. "Danny" Diggs: yes
    • Tara A. Durant: no
    • Barbara A. Favola: yes
    • Timmy French: no
    • T. Travis Hackworth: yes
    • Christopher T. Head: yes
    • Michael J. Jones: yes
    • Emily M. Jordan: yes
    • Mamie E. Locke: yes
    • L. Louise Lucas: yes
    • David W. Marsden: yes
    • Ryan T. McDougle: no
    • Jeremy S. McPike: yes
    • Tammy Brankley Mulchi: no
    • Mark D. Obenshain: no
    • Mark J. Peake: yes
    • Stella G. Pekarsky: yes
    • Russet Perry: yes
    • Todd E. Pillion: yes
    • Bryce E. Reeves: yes
    • Danica A. Roem: yes
    • Aaron R. Rouse: yes
    • Saddam Azlan Salim: yes
    • Kannan Srinivasan: yes
    • William M. Stanley, Jr.: yes
    • Richard H. Stuart: yes
    • Glen H. Sturtevant, Jr.: yes
    • David R. Suetterlein: yes
    • Scott A. Surovell: yes
    • Schuyler T. VanValkenburg: yes
    • Angelia Williams Graves: yes

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:35:59.552682Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=VA&identifier=SB 271. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.